Urine Output as a Novel Predictor for In-Hospital Mortality in Acute Pulmonary Embolism Patients: Training With the MIMIC Database and Validation With Independent Cohort

IF 3.4 4区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Wenjia Ai, Fangfei Li, Qilin Yang, Jingluo Qiu, Aiqiang Zhou, Yinqian Huang, Baohui Xu, Zhihui Zhang
{"title":"Urine Output as a Novel Predictor for In-Hospital Mortality in Acute Pulmonary Embolism Patients: Training With the MIMIC Database and Validation With Independent Cohort","authors":"Wenjia Ai,&nbsp;Fangfei Li,&nbsp;Qilin Yang,&nbsp;Jingluo Qiu,&nbsp;Aiqiang Zhou,&nbsp;Yinqian Huang,&nbsp;Baohui Xu,&nbsp;Zhihui Zhang","doi":"10.1155/cdr/7907049","DOIUrl":null,"url":null,"abstract":"<p><b>Background:</b> Identifying high-risk patients with acute pulmonary embolism is vital for improving disease prognosis. However, current guidelines and research on risk factors are insufficient to meet clinical needs. This study was aimed at exploring novel risk factors to predict in-hospital mortality.</p><p><b>Methods:</b> We utilized a patient cohort from the Medical Information Mart for Intensive Care Version IV (MIMIC-IV) database as training cohort. Major analyses included screening risk factors for in-hospital mortality, correlation analysis via smooth curve fitting, multivariate Cox regression, and subgroup analysis. The findings were further validated with our own institute patient cohort.</p><p><b>Results:</b> Among 1463 adult patients with acute pulmonary embolism in the MIMIC-IV database, the overall in-hospital mortality rate was 17.8%. A nonlinear correlation was observed between urine output and in-hospital mortality. A urine discharge less than 0.85 mL/kg/h was used as the threshold and was negatively associated with the risk for in-hospital death. Compared to patients with urine value &lt; 0.5 mL/kg/h, the risk for in-hospital mortality reduced by 36% and 48% in patients with urine values of 0.5–0.85 mL/kg/h and &gt; 0.85 mL/kg/h, with the hazard ratios of 0.64 (0.47, 0.87) and 0.52 (0.38, 0.72), respectively. This association remained significant in the subgroup analysis after adjusting for age, gender, hypotension, and low oxygen saturation. Our validation patient cohort (<i>n</i> = 151) further confirmed the strong association of the urine value with in-hospital mortality and consistent cutoff value.</p><p><b>Conclusion:</b> Our study revealed a negative association of urine output with in-hospital mortality in acute pulmonary embolism patients, with the optimal urine output being significantly higher than the value of other critical illnesses.</p>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2025 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/cdr/7907049","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/cdr/7907049","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Identifying high-risk patients with acute pulmonary embolism is vital for improving disease prognosis. However, current guidelines and research on risk factors are insufficient to meet clinical needs. This study was aimed at exploring novel risk factors to predict in-hospital mortality.

Methods: We utilized a patient cohort from the Medical Information Mart for Intensive Care Version IV (MIMIC-IV) database as training cohort. Major analyses included screening risk factors for in-hospital mortality, correlation analysis via smooth curve fitting, multivariate Cox regression, and subgroup analysis. The findings were further validated with our own institute patient cohort.

Results: Among 1463 adult patients with acute pulmonary embolism in the MIMIC-IV database, the overall in-hospital mortality rate was 17.8%. A nonlinear correlation was observed between urine output and in-hospital mortality. A urine discharge less than 0.85 mL/kg/h was used as the threshold and was negatively associated with the risk for in-hospital death. Compared to patients with urine value < 0.5 mL/kg/h, the risk for in-hospital mortality reduced by 36% and 48% in patients with urine values of 0.5–0.85 mL/kg/h and > 0.85 mL/kg/h, with the hazard ratios of 0.64 (0.47, 0.87) and 0.52 (0.38, 0.72), respectively. This association remained significant in the subgroup analysis after adjusting for age, gender, hypotension, and low oxygen saturation. Our validation patient cohort (n = 151) further confirmed the strong association of the urine value with in-hospital mortality and consistent cutoff value.

Conclusion: Our study revealed a negative association of urine output with in-hospital mortality in acute pulmonary embolism patients, with the optimal urine output being significantly higher than the value of other critical illnesses.

Abstract Image

尿量作为急性肺栓塞患者住院死亡率的新预测指标:MIMIC数据库训练和独立队列验证
背景:识别急性肺栓塞高危患者对改善疾病预后至关重要。然而,目前关于危险因素的指南和研究不足以满足临床需要。本研究旨在探讨预测住院死亡率的新危险因素。方法:我们使用重症监护医学信息市场IV版(MIMIC-IV)数据库中的患者队列作为培训队列。主要分析包括筛选院内死亡率的危险因素、平滑曲线拟合的相关性分析、多变量Cox回归和亚组分析。研究结果在我们自己的研究所患者队列中得到进一步验证。结果:在MIMIC-IV数据库中的1463例急性肺栓塞成人患者中,总体住院死亡率为17.8%。尿量与住院死亡率呈非线性相关。尿量低于0.85 mL/kg/h作为阈值,与院内死亡风险呈负相关。患者尿值<;0.5 mL/kg/h, 0.5 ~ 0.85 mL/kg/h和0.85 mL/kg/h患者住院死亡风险分别降低36%和48%,风险比分别为0.64(0.47,0.87)和0.52(0.38,0.72)。在调整了年龄、性别、低血压和低氧饱和度等因素后,亚组分析中这种关联仍然显著。我们的验证患者队列(n = 151)进一步证实了尿值与住院死亡率的强相关性和一致的截止值。结论:我们的研究显示急性肺栓塞患者的尿量与住院死亡率呈负相关,且最佳尿量明显高于其他危重疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular Therapeutics
Cardiovascular Therapeutics 医学-心血管系统
CiteScore
5.60
自引率
0.00%
发文量
55
审稿时长
6 months
期刊介绍: Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged. Subject areas include (but are by no means limited to): Acute coronary syndrome Arrhythmias Atherosclerosis Basic cardiac electrophysiology Cardiac catheterization Cardiac remodeling Coagulation and thrombosis Diabetic cardiovascular disease Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF) Hyperlipidemia Hypertension Ischemic heart disease Vascular biology Ventricular assist devices Molecular cardio-biology Myocardial regeneration Lipoprotein metabolism Radial artery access Percutaneous coronary intervention Transcatheter aortic and mitral valve replacement.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信